KDM3A
protein-codinglysine demethylase 3A, the group of Lysine demethylases
Gene summary
Enables histone H3K9me/H3K9me2 demethylase activity; iron ion binding activity; and nuclear androgen receptor binding activity. Involved in androgen receptor signaling pathway; formaldehyde biosynthetic process; and positive regulation of DNA-templated transcription. Located in nucleoplasm. Implicated in cervical cancer and colon cancer. Biomarker of Ewing sarcoma; hepatocellular carcinoma; nasopharynx carcinoma; and prostate cancer. [provided by Alliance of Genome Resources, Jul 2025]
- JMJD1
- JMJD1A
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~52.1 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0100038
Submitter: LiferaOmics
Genetic evidence – Published (AR scope): No scorable published cases of biallelic (autosomal recessive) KDM3A variants causing neurodevelopmental disorder were identified in the current literature review. Available published human data primarily describe heterozygous (autosomal dominant) de novo variants, which are outside the scope of this AR GDR. Case-level = 0; segregation = 0; case-control = 0 Published (AD context; not scored for AR): PMID: 27748065 – Reports a heterozygous intragenic deletion involving KDM3A identified in an intellectual disability cohort; interpreted in an autosomal dominant framework. As this represents monoallelic/dominant evidence, it is not scorable under the autosomal recessive model. Case-level = 0 (AR scope); segregation = 0; case-control = 0 PMID: 36702863 – Whole-genome sequencing study identifying de novo heterozygous variants in KDM3A in individuals with autism spectrum disorder; association-level evidence under a dominant model and not applicable to AR scoring. Case-level = 0 (AR scope); segregation = 0; case-control = 0 AD-context evidence total (not scored for AR) = 0 Published genetic evidence total = 0/12 Genetic evidence – Our cases: Family 1 – one proband. Case-level (predicted loss-of-function variant in AR model; homozygous scored once; −0.5 consanguinity deduction applied) = 0.5; segregation = 0; case-control = 0; Family 1 total = 1.0 Our cases total = 1.0/12 Total genetic evidence (published AR + our cases) 1.0/12 Experimental evidence – Published: PMID: 29276005 – Demonstrates that KDM3A functions as an H3K9 demethylase regulating neuronal differentiation programs; knockdown experiments impair neurodevelopmental pathways with rescue supporting specificity. Function consistent with disease = 0.5 PMID: 29042477 – Shows that KDM3A is required for primary neurogenesis and Neurog2-mediated neuronal differentiation in Xenopus, with knockdown and rescue experiments supporting a critical role in neuronal development. Functional alteration in model system = 0.5 PMID: 40033066 – Mouse model studies demonstrate that Kdm3a regulates postnatal hippocampal neurogenesis and affects learning and memory, supporting relevance to neurodevelopmental processes. Model organism evidence = 0.5 Experimental evidence total = 1.5/6 Overall score Genetic evidence = 1.0 Experimental evidence = 1.5 Overall score = 2.5
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to KDM3A variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_018433.6. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 6 | 10 | 8 | 24 | ||
| missense | 142 | 9 | 2 | 153 | ||
| nonsense | 2 | 2 | ||||
| start loss | 0 | |||||
| frameshift | 2 | 2 | ||||
| splice donor/acceptor (+/-2bp) | 10 | 10 | ||||
| Total | 0 | 0 | 162 | 19 | 10 | 191 |
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_060903.2 | 25 | MANE Select | |
| Ensembl | ENSP00000323659.5 | 25 | MANE Select | |
| RefSeq | NP_001140160.1 | 25 | Standard | |
| Ensembl | ENSP00000386516.1 | 25 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Thermogenesis - Homo sapiens (human)
- HDMs demethylate histones
- Chromatin modifying enzymes
- AndrogenReceptor
- Coregulation of Androgen receptor activity
Biological Process
- spermatid nucleus elongation
- hormone-mediated signaling pathway
- androgen receptor signaling pathway
- histone H3-K9 demethylation
- histone H3-K9 dimethylation
Molecular Function
- transcription regulatory region sequence-specific DNA binding
- RNA polymerase II core promoter sequence-specific DNA binding
- DNA-binding transcription factor activity
- iron ion binding
- protein binding
Cellular Component
- chromatin
- nucleus
- nucleoplasm
- cytoplasm
- membrane
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000409556
- Coding exons
- 25
- Length
- 52070
- Individuals with no LoFs
- 125734
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 12
- Defined
- 125746
- p
- 0.0000477
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 1.65 | 573 | 695 | 0.824 | 0.0000351 | 8677 |
| Missense (PolyPhen) | 215 | 339.83 | 0.63268 | 4131 | ||
| Synonymous | -2.16 | 294 | 251 | 1.17 | 0.0000129 | 2500 |
| Loss of Function | 6.86 | 9 | 71.7 | 0.125 | 0.00000398 | 841 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0 | 0.0 | absent |
| Latino/Admixed American | 0.000029 | 0.000029 | rare |
| Ashkenazi Jewish | 0.00022 | 0.00020 | rare |
| East Asian | 0.000054 | 0.000054 | rare |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0.000044 | 0.000044 | rare |
| South Asian | 0.00010 | 0.000098 | rare |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Histone demethylase that specifically demethylates 'Lys- 9' of histone H3, thereby playing a central role in histone code. Preferentially demethylates mono- and dimethylated H3 'Lys-9' residue, with a preference for dimethylated residue, while it has weak or no activity on trimethylated H3 'Lys-9'. Demethylation of Lys residue generates formaldehyde and succinate. Involved in hormone-dependent transcriptional activation, by participating in recruitment to androgen-receptor target genes, resulting in H3 'Lys-9' demethylation and transcriptional activation. Involved in spermatogenesis by regulating expression of target genes such as PRM1 and TNP1 which are required for packaging and condensation of sperm chromatin. Involved in obesity resistance through regulation of metabolic genes such as PPARA and UCP1. {ECO:0000269|PubMed:16603237, ECO:0000269|PubMed:28262558}.;
Recessive Scores
- pRec
- 0.112
Intolerance Scores
- LoFtool
- 0.377
- RVIS EVS
- -0.73
- RVIS percentile EVS
- 14.24
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.925
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |